Selective and reversible inhibitor of inosine monophosphate dehydrogenase I/II
REVIEW An an immunosuppressant and prodrug of mycophenolic acid, used extensively in transplant medicine. Mycophenolate mofetil is a non-competitive, selective and reversible inhibitor of inosine monophosphate dehydrogenase I/II
Clayton PA, McDonald SP, Chapman JR, Chadban SJ (2012). Mycophenolate versus azathioprine for kidney transplantation: a 15-year follow-up of a randomized trial. Transplantation. 94(2):152-8. PMID 22728292.
Sodikoff JB, Keilin SA, Cai Q, Bharmal SJ, Lewis MM, Raju GS, Willingham FF (2012). Mycophenolate mofetil for maintenance of remission in steroid-dependent autoimmune pancreatitis. World J Gastroenterol. 18(18):2287-90. PMID 22611324.
These chemical products are for research and development use only. They are not for diagnostic, therapeutic, cosmetic, or human and animal uses. They are not sold to individuals. Additional restrictions may apply.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information.